✦ LIBER ✦

197 A phase I and pharmacokinetic (PK) study of an agonistic, fully human monoclonal antibody, HGS-ETR2, to the TNF-alpha related apoptosis inducing ligand receptor 2 (TRAIL R2) in patients with advanced cancer

✍ Scribed by J. de Bono; G. Attard; R. Plummer; S. Pacey; C. Bale; L. Vidal; A. Greystoke; N. Fox; A. Corey; H. Calvert

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

208 HGS-ETR1, a fully human monoclonal a

✍ S.J. Hotte; A.M. Oza; L.H. Le; M. MacLean; A. Iacobucci; A. Corey; N.L. Fox; H.W 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Phase 2 study of mapatumumab, a fully hu

✍ Greco, F. Anthony; Bonomi, Philip; Crawford, Jeffrey; Kelly, Karen; Oh, Yun; Hal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Phase II Trial of Mapatumumab, a Fully H

✍ von Pawel, Joachim; Harvey, Jimmie H.; Spigel, David R.; Dediu, Mircea; Reck, Ma 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 569 KB

A phase I pharmacokinetic (PK) and seria

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 256 KB